ACC Highlights 2020 - What You Need To Know
Details & Video
Program details and agenda: Select TABS on the left (computer) or SCROLL DOWN (phone)
Overview & Objectives
This program will cover the key clinical trial findings and their implications from ACC 2020. This program is intended for cardiovascular specialists and primary care physicians from across Canada.
This program is NOT accredited.
Mainpro+ participants may earn certified credits by completing a Linking Learning Exercise.
Specialist participants may claim Section 2 credits (up to 2 credits per hour) following completion of a personal learning project (PLP) under Section 2: Self-Learning Activities within the MAINPORT ePortfolio.
You will receive a Certificate of Attendance for your records following completion of the session evaluation form.
|- New data from PARAGON-HF|
|Peripheral artery disease|
|- COMPASS DM|
|- Homozygous FH|
|- EPA levels in REDUCE-IT|
|- New data from ODYSSEY Outcomes|
|- Evolocumab for HIV patients|
|Structural heart disease|
|- Updates in TAVR|
Amgen Canada Inc.
Bristol Meyers Squibb